Table 1 Characteristics of included studies (n = 10).
Study (year) | Age (years) | Male (%) | BMI (kg/m2) | Procedure | ED | n | Airway device size | Definition of HCP (cmH2O) | Incidence of HCP | Mean CP change (cmH2O) | NOS |
|---|---|---|---|---|---|---|---|---|---|---|---|
Tan 201124 | 60.3 | 79 | 25.1 | CS | TEE probe | 38 | 7–7.5 mm¶ | > 35 | 45% | 8.5 | 8 |
Hung 201427 | 34 | 28.3 | 37.7 | BS | OG tube | 60 | 7–8 mm¶ | > 30 | 50% | 8.3 | 8 |
Kim 201529 | 66.8¶; 61.8‡ | 86.4¶ 59.1‡ | 23.4¶ 23.7‡ | CS | TEE probe | 44 | 7–7.5 mm¶, 32-39Fr‡ | > 40 | 18.2%¶, 40.9%‡ | 6.9 12 | 8 |
Ozayar 201630 | 38 | 35 | 44.5 | BS | OG tube | 40 | 7.5–8 mm¶ | NA | NA | 5.6 | NA§ |
Balaban 201725 | 11.3 | 50 | NA | EGD | EGD probe | 13 | NA¶ | NA | NA | 5 | 8 |
Kamata 201728 | 0.5–14 | NA | 15.3–20.3 | CS | TEE probe | 80 | 3–7 mm¶ | > 30 | 22.50% | 3.6 | 8 |
Borde 202026 | 55 | 69.3 | 23.3 | CS | TEE probe | 65 | 7–8.5 mm¶ | > 30 | 40% | 8 | 8 |
Pan 202031 | 2.9–24.6 | 60.3 | 22.2 | CS | TEE probe | 58 | 3–7.5 mm¶ | > 30 | 23–77.5% | 3–12.3 | 8 |
Maddali 202240 | 55.7 | 73.5 | 28.7 | CS | TEE probe | 34 | 7.5–9 mm¶ | NA | NA | 20.3 | 8 |
Parajuli 202141 | 40.5 | 61.1 | 23.6 | CS | TEE probe | 36 | 7–7.5 mm¶ | > 30 | 50% | 7.64 | 8 |
